Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One

Veradermics Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One increased by 153.9% to $289.40M in Q1 2026 compared to the prior quarter.

Analysis

StatementBalance Sheet Statement

SectionOther

CategoryLiquidity

SignalContext dependent

VolatilityStable

First reportedQ4 2025

Last reportedQ1 2026

How to read this metric

Higher values indicate higher near-term liquidity and potential for reinvestment at current market rates.

Detailed definition

The amortized cost of available-for-sale debt securities maturing within one year. This metric provides insight into the...

Peer comparison

Standard maturity profile disclosure for investment portfolios in the banking industry.

Metric ID: other_available_for_sale_securities_debt_maturities_with_72951f

Historical Data

2 periods

	Q4 '25	Q1 '26
Value	$114.00M	$289.40M
QoQ Change	—	+153.9%

Range$114.00M – $289.40M

Frequently Asked Questions

What is Veradermics 's debt securities, available-for-sale, amortized cost, maturity, allocated and single maturity date, year one?: Veradermics (MANE) reported debt securities, available-for-sale, amortized cost, maturity, allocated and single maturity date, year one of $289.40M in Q1 2026.
What does debt securities, available-for-sale, amortized cost, maturity, allocated and single maturity date, year one mean?: The value of investment securities that will mature within the next year.